Radiologist Stephen L. Rose, M.D., knows that experienced breast radiologists paired with state-of-the-art equipment can make a life-saving difference in the early detection and diagnosis of breast cancer. A board-certified breast radiologist, Dr. Rose has been a big believer in the potential for tomosynthesis technology for more than five years.


As meaningful use standards become a crucial component of medical care, many hospitals and clinics are looking to upgrade or even fully replace their picture archive and communication systems (PACS). Such a switch is not something to be taken lightly, and the solution often isn’t as simple as “plug and play.” Typically, hundreds of thousands of images from numerous modalities need to be converted to the new system. And aside from choosing a system that best suits their individual needs, organizations need to consider a range of factors, from network security and HIPAA to cost and staff training.

As the imaging industry has looked for methods to achieve lower doses, especially in computed tomography (CT), many systems vendors have focused on utilizing software as one way to do it. GE Healthcare and Siemens are two of the companies offering dose reduction software technologies. Described below are their products and recent efforts.

The use of computed tomography (CT), magnetic resonance imaging (MRI) and other high-tech diagnostic imaging (HTDI) scans increased 8 percent a year from 2003 to 2006 in Minnesota. There was concern that this potential overuse could expose patients to unnecessary radiation, plus contribute significantly to unsustainable increases in healthcare costs.

Founded in 2010 by Helen Mrose, M.D., Bay Radiology provides advanced screening and diagnostic digital mammography, screening and diagnostic breast ultrasound, ultrasound-guided cyst aspiration, ultrasound-guided core biopsy and stereotactic core biopsy.

This article appeared as the introduction to the CT Dose Reduction comparison chart.

Radialsource Transradial Sheath

May 17, 2011 – iCAD, an industry-leading provider of advanced image analysis, workflow solutions and radiation therapies for the early identification and treatment of cancer, announces that it has secured regulatory approval for its SecondLook Digital by the State Food and Drug Administration (SFDA) in the People’s Republic of China. The approval allows iCAD’s SecondLook Digital computer-aided detection (CAD) technology to be sold with GE Digital Mammography Systems in order to assist radiologists in distinguishing potential cancers from other anomalies on a mammogram.

May 17, 2011 - Gamma Medica and Mayo Clinic of Rochester, Minn., document the achievement of a five-fold reduction in the necessary dose of Tc-99m sestamibi to perform molecular breast imaging (MBI). This achievement enables the new LumaGEM MBI System by Gamma Medica to deliver the same low radiation dose as digital screening mammography.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now